Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Bosentan in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

NCT00313222 is registered in ClinicalTrials.gov with Actelion as lead sponsor.

NCT NCT00313222
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00313222 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Bosentan in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Lead sponsor
Actelion
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2005
Completion date
March 31, 2007
Enrollment
157 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic thromboembolic pulmonary hypertension